Welcome
The Oncology area of Gradient Biotech is a web workspace for multi-omic, spatial, and clinical oncology research. It builds on the Computational Biology foundation — single-cell, spatial, bulk RNA-seq, and biomarker pipelines — and extends it with oncology-specific capabilities: cell-cell communication, immune profiling, mutation landscape analysis, and clinical outcome integration.
What you can do today
| Capability | Status |
|---|---|
| Study and cohort management | Tumor type, stage, treatment arm, response status, sample metadata |
| Clinical endpoints | Survival, recurrence, and response records linked to patients |
| Mutation datasets | MAF/VCF ingestion records with per-sample variant tables |
| Repertoire datasets | TCR/BCR sequencing file records for clonotype analysis |
| Tumor microenvironment | TME composition view (calls compbio single-cell infrastructure) |
| Cell-cell communication | Ligand-receptor scoring, pathway aggregation, condition comparison |
| Immuno-oncology profiling | Deconvolution, TIDE-like phenotype, exhaustion, repertoire metrics |
| Mutation landscape | TMB, signatures, oncoprint, copy number, driver pathway enrichment |
| Survival analysis | Kaplan-Meier, log-rank testing, Cox regression, longitudinal trajectories |
| AI interpretation | Grounded summaries for communication, immune, mutation, and survival outputs |
| Run history | Study-level pipeline run tracking with artifact links |
How the product is organized
Every analysis lives inside a study — your oncology project container. From the oncology dashboard you create or open a study, then work through:
- Overview — study metadata, workflow cards, and run history
- Data — samples, clinical endpoints, mutation and repertoire datasets
- TME — tumor microenvironment composition (compbio-backed)
- Communication — ligand-receptor and signaling network analysis
- Immune — deconvolution, immune phenotype, exhaustion, and repertoire profiling
- Mutations — somatic mutation landscape and oncoprint summaries
- Survival — clinical endpoint analysis stratified by molecular features
- Interpret — AI-assisted summaries grounded in completed pipeline outputs
Pipeline jobs run asynchronously. Launch jobs from workflow pages and refresh when complete.
Who this is for
- Tumor biology researchers studying cell-cell communication, spatial TME mapping, and immune infiltration
- Translational oncology teams correlating mutation landscapes with therapy response and survival
- Immuno-oncology researchers profiling exhaustion states, repertoire diversity, and IO response phenotypes
- Computational oncology groups running reproducible multi-omic pipelines with full provenance
What this is not
- Not a regulated clinical diagnostic or clinical decision support tool
- Not a replacement for established algorithms — it orchestrates and modernizes them
- Not a standalone single-modality tool — value compounds as more data types connect within a study
Next steps
- Use cases — scenario guides for IO response, mutation-outcome, TME signaling, and multi-omic integration
- Quick start — create a study and run your first oncology pipeline
- Key concepts — studies, samples, runs, and artifacts
- Study workflow — how the main sections fit together